• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血管扩张剂在慢性缺血性心脏病患者潜在心力衰竭中的疗效]

[Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].

作者信息

Volkov V S, Bratoliubov V P

出版信息

Kardiologiia. 1984 Aug;24(8):89-92.

PMID:6436573
Abstract

The tolerance to exercise and parameters of the central hemodynamics were studied in 111 patients with coronary heart disease and latent cardiac failure. It has been ascertained that they have a considerably increased peripheral resistance. The treatment with erinit and nitrong improves the propulsive function of the heart and diminishes significantly the peripheral resistance which results in an increased tolerance to physical load. The latter depends on the degree of the peripheral resistance decrease due to erinit and nitrong. Vasodilating agents may be useful in preventing the progression of heart failure in patients with coronary heart disease.

摘要

对111例冠心病合并潜在心力衰竭患者的运动耐受性和中心血流动力学参数进行了研究。已确定他们的外周阻力显著增加。使用依诺昔酮和硝普钠治疗可改善心脏的推进功能,并显著降低外周阻力,从而提高对体力负荷的耐受性。后者取决于依诺昔酮和硝普钠导致的外周阻力降低程度。血管扩张剂可能有助于预防冠心病患者心力衰竭的进展。

相似文献

1
[Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].[血管扩张剂在慢性缺血性心脏病患者潜在心力衰竭中的疗效]
Kardiologiia. 1984 Aug;24(8):89-92.
2
[Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
Ter Arkh. 1986;58(5):124-7.
3
[Options of NO substitution: proven and future methods. A pharmaceutical classic on the upswing].[一氧化氮替代的选择:已证实的方法与未来方法。一部正在兴起的药学经典著作]
MMW Fortschr Med. 2011 Jun 16;153(24-25):50-1.
4
[Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].[戊四硝酯(PETN)治疗。已证实的有效性,再次接受试验]
MMW Fortschr Med. 2011 Feb 17;153(7):44-5.
5
[Nitroderivatives. Novelty on old drugs].
Ann Ital Med Int. 1987 Jul-Sep;2(3):236-41.
6
[Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
Nouv Presse Med. 1979 Jan 23;8(4):293-6.
7
[Comparative study of the treatment of angina pectoris with nitrong, papaverine, erinit and euphylline].
Sov Med. 1985(7):77-80.
8
[Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance].冠心病的长期硝酸盐治疗——因产生耐受性而失效
Z Gesamte Inn Med. 1990 Dec 15;45(24):736-41.
9
[Drug treatment of chronic coronary disease].[慢性冠状动脉疾病的药物治疗]
Wiad Lek. 1980 Jan 15;33(2):107-11.
10
[Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1981;4(1):59-64.